Small Budget Impact Is a Result of Flawed Assumptions and Ignores Questionable Cost-Effectiveness for RSV Prophylaxis
Jul 1, 2010, 00:00
10.1111/j.1524-4733.2010.00723.x
https://www.valueinhealthjournal.com/article/S1098-3015(10)60114-3/fulltext
Title :
Small Budget Impact Is a Result of Flawed Assumptions and Ignores Questionable Cost-Effectiveness for RSV Prophylaxis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)60114-3&doi=10.1111/j.1524-4733.2010.00723.x
First page :
Section Title :
Open access? :
No
Section Order :
25
Leonard Krilov and colleagues present their study “Prevalence of Respiratory Syncytial Virus (RSV) Risk Factors and Cost Implications of Immunoprophylaxis to Infants 32 to 35
Weeks Gestation for Health Plans in the United States” in the January 2010 issue of Value in Health [1]. We take this opportunity to express our concerns about the study’s methodology and conclusions.
Categories :
- Budget Impact Analysis
- Cost-comparison, Effectiveness, Utility, Benefit Analysis
- Economic Evaluation
- Respiratory-Related Disorders
- Specific Diseases & Conditions